World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
58
Citations
11382
World Ranking
3533
National Ranking
79

Gunnar Norkrans publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gunnar Norkrans sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 229 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gunnar Norkrans D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gunnar Norkrans sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gunnar Norkrans is affiliated with the University of Gothenburg in Sweden. Their research primarily focuses on medical studies, with significant contributions in the fields of epidemiology, hepatology, pathology and forensic medicine, as well as endocrinology, diabetes, and metabolism.

Their work spans several main topics, including hepatitis B virus studies, hepatitis C virus research, liver disease diagnosis and treatment, hepatitis viruses studies and epidemiology, vitamin D research studies, microscopic colitis, and adrenal hormones and disorders.

Frequent collaborators in Gunnar Norkrans's research include Maria Andersson, Magnus Lindh, Staffan Nilsson, Gustaf E. Rydell, and Simon B. Larsson.

They have published in various journals, notably:

  • The Journal of Infectious Diseases
  • Hepatology Communications
  • Journal of Viral Hepatitis
  • PLoS ONE
  • Scandinavian Journal of Gastroenterology

The following are some of the recent papers associated with Gunnar Norkrans's research, highlighting their ongoing work in liver diseases and viral hepatitis:

  • Abundance of Noncircular Intrahepatic Hepatitis B Virus DNA May Reflect Frequent Integration Into Human DNA in Chronically Infected Patients, 2020, The Journal of Infectious Diseases
  • Hepatitis B Virus RNA Profiles in Liver Biopsies by Digital Polymerase Chain Reaction, 2020, Hepatology Communications
  • Long-Term Outcome of Chronic Hepatitis B-Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma, 2025, Journal of Viral Hepatitis
  • The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection, 2020, PLoS ONE
  • Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus, 2021, Scandinavian Journal of Gastroenterology

The research emphasizes evaluation of viral infections of the liver, including hepatitis B and C viruses, with attention to molecular profiles, immunological factors, and clinical outcomes. Their work also explores the role of vitamin D levels in liver disease and the interaction between viral load and immune responses.

Best Publications

  • Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

    Olle Reichard;Gunnar Norkrans;Aril Frydén;Jean-Henrik Braconier

  • Core Promoter Mutations and Genotypes in Relation to Viral Replication and Liver Damage in East Asian Hepatitis B Virus Carriers

    Magnus Lindh;Charles Hannoun;Amar P. Dhillon;Gunnar Norkrans

  • Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

    Geoffrey Dusheiko;Janice Main;Howard Thomas;Olle Reichard

  • Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

    Johan Westin;Hans Nordlinder;Martin Lagging;Gunnar Norkrans

  • A significant sex--but not elective cesarean section--effect on mother-to-child transmission of hepatitis C virus infection

    A. Amoroso;F. Asensi-Botet;A. Pereda;V. Balossini

  • Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.

    M Lindh;P Horal;A P Dhillon;G Norkrans

  • IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.

    Martin Lagging;Ana I. Romero;Johan Westin;Gunnar Norkrans

  • Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection.

    J Westin;L M Lagging;R Wejstål;G Norkrans

  • High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-α2b for 60 weeks

    Olle Reichard;Ulla Foberg;Aril Frydén;Lars Mattsson

  • Mother‐to‐infant transmission of hepatitis C virus

    R. Wejstal;A. Widell;A.-S. Mansson;S. Hermodsson

  • Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection.

    Johan Westin;L M Lagging;N Aires

  • Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon

    Magnus Lindh;Jorge E Gonzalez;Gunnar Norkrans;Peter Horal

  • Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection.

    Martin Lagging;Nina Langeland;Court Pedersen;Martti Färkkilä

  • Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon

    Olle Reichard;Hans Glaumann;Aril Frydén;Gunnar Norkrans

  • Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission

    Ann Söderström;Gunnar Norkrans;Magnus Lindh

  • Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

    Olle Reichard;Hans Glaumann;Aril Frydén;Gunnar Norkrans

  • Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.

    Dietmar Fuchs;Francesca Chiodi;Jan Albert;Birgitta Asjö

  • Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.

    Peter Derek Christian Leutscher;Martin Lagging;Mads Rauning Buhl;Court Pedersen

  • Immune activation and decreased tryptophan in patients with HIV-1 infection.

    D. Fuchs;A. Forsman;L. Hagberg;M. Larsson

  • Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage

    M Lindh;P Horal;A P Dhillon;Y Furuta

  • Systemic and intrahepatic interferon‐gamma‐inducible protein 10 kDa predicts the first‐phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

    Galia Askarieh;Åsa Alsiö;Paolo Pugnale;Francesco Negro

Frequent Co-Authors

Magnus Lindh
Magnus Lindh University of Gothenburg
Lars Hagberg
Lars Hagberg Sahlgrenska University Hospital
Ola Weiland
Ola Weiland Karolinska University Hospital
Kristoffer Hellstrand
Kristoffer Hellstrand University of Gothenburg
Nina Langeland
Nina Langeland Haukeland University Hospital
Martti Färkkilä
Martti Färkkilä University of Helsinki
Court Pedersen
Court Pedersen Odense University Hospital
Amar P. Dhillon
Amar P. Dhillon University College London
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Francesca Chiodi
Francesca Chiodi Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers, many of which can be complemented by advanced nursing degrees. For those interested in entering the nursing field quickly, exploring the easiest absn programs to get into can be a strategic first step. These accelerated programs offer a fast track to becoming a registered nurse, which is valuable for individuals aiming to work closely with immunology-related healthcare.

Alternatively, entering as a licensed practical nurse can be achieved through some of the fastest and easiest lpn programs, providing foundational clinical experience that is beneficial in both immunology research and patient care roles. For nurses looking to advance their expertise, the easiest nurse practitioner program options make it more accessible to obtain specialized qualifications, which often include immunology-related specialties.

Moreover, for those interested in the mental health aspects of immunology, pursuing one of the best psychiatric mental health nurse practitioner programs online can provide excellent clinical placements with a focus on patient care and immunological impacts on mental health.

Exploring these online degrees and related pathways can complement an immunology career by developing clinical skills, accelerating entry into the healthcare workforce, and expanding specialty options.

Best Scientists Citing Gunnar Norkrans

Trending Scientists

Recently Published Articles